Department of Biological Science, Kongju National University, Gongju 314-701, South Korea.
Neuromuscul Disord. 2013 Aug;23(8):656-63. doi: 10.1016/j.nmd.2013.05.009. Epub 2013 Jun 21.
Charcot-Marie-Tooth disease (CMT) is a group of clinically and genetically heterogeneous peripheral neuropathies. HSPB8 gene encodes heat shock protein 22 (HSP22) which belongs to the superfamily of small stress induced proteins. Mutations in HSPB8 are implicated to CMT2L and distal hereditary motor neuropathy 2A (dHMN2A). All three reported HSPB8 mutations are interestingly located in the Lys141 residue. In the present study, we examined a Korean axonal CMT patient who presented distal limb atrophy, sensory loss, areflexia, and axonal loss of large myelinated fibers. Whole exome sequencing identified a novel missense mutation c.422A>C (p.Lys141Thr) in HSPB8 as the underlying cause of the CMT2 patient. The mutation was regarded as a de novo case because both unaffected parents have no such mutation. The patient with HSPB8 mutation is the first case in Koreans. Clinical heterogeneities have been revealed in patients with Lys141 mutation; the present patient revealed similar phenotype of CMT2L. In addition, the lower limb MRI revealed a similarity between our HSPB8 and HSPB1 patients. It seems that the Lys141 site in the alpha-crystallin domain of HSPB8 is regarded as a mutational hot spot for peripheral neuropathy development, and mutations even in the same codon can exhibit different CMT phenotypes.
遗传性运动感觉神经病 2L 型和 2A 型(CMT2L 和 dHMN2A)是由 HSPB8 基因突变引起的。所有报道的 HSPB8 突变都位于赖氨酸 141 残基。在本研究中,我们对一名韩国轴索型 CMT 患者进行了检查,该患者表现为远端肢体萎缩、感觉丧失、反射消失和大髓鞘纤维的轴索性丧失。全外显子组测序发现 HSPB8 中的一个新错义突变 c.422A>C(p.Lys141Thr),这是该 CMT2 患者的致病原因。该突变被认为是新生病例,因为未受影响的父母均无此突变。该 HSPB8 突变患者是韩国首例。Lys141 突变患者的临床表现存在异质性;本患者表现出与 CMT2L 相似的表型。此外,下肢 MRI 显示我们的 HSPB8 和 HSPB1 患者之间存在相似性。似乎 HSPB8 的α-晶体蛋白结构域中的赖氨酸 141 位点被认为是周围神经病变发展的突变热点,即使在相同密码子中发生突变也可能表现出不同的 CMT 表型。